Proteins provide remarkably diverse functionality in living systems by interacting and self-assembling together with other proteins into complexes, which represent key components of the nano-scale machinery of life (1). Such self-assembly processes generate intricate structures of considerable complexity that can perform a wide variety of functional roles, which range from generating motion to controlling transport across membranes. Where assembly processes are involved, there is, however, an inherent danger of misassembly, which can occur when a protein binds an incorrect partner or interacts with the appropriate partner in an incorrect manner. These types of aberrant behavior can lead to the formation of dysfunctional and even toxic molecular species. A particularly striking example of such misbehavior is the formation of amyloid fibrils (2), highly ordered elongated structures initially identified through their association with neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases (3, 4) . This kind of pathological protein self-assembly is now known to occur in the context of more than 30 disorders, and the associated neurodegenerative diseases have been estimated to affect about 45 million people worldwide, a number that is expected to triple in the next 35 y as a consequence of the general increase in life expectancy in modern societies and the fact that aging is one of the key risk factors for this class of protein misfolding diseases (5) . Hence, there is an urgent need for progresses in diagnosis and drug development against this class of disorders (6) . A fundamental prerequisite to achieve these goals is a detailed understanding of the molecular mechanisms underlying the aberrant assembly of peptides and proteins, and how these mechanisms can be perturbed by the presence of other compounds. A crucial advance in this direction is presented in the PNAS report by Abelein et al. (7), which reveals the mechanism underlying the inhibition activity of the metal ion zinc against the aggregation of the amyloid β (Aβ) peptide, a peptide associated with Alzheimer's disease.
Understanding the molecular mechanisms underlying the misbehavior of peptides and proteins represents a great challenge. Indeed, the self-assembly of proteins into amyloid fibrils is a complex multistep process, which is driven by a range of microscopic reactions that are intricately connected, including nucleation events, which result in the formation of new aggregates, and growth processes, which lead to the increase in length of existing fibrils. A further complication of this picture is the fact that the nucleation processes can be facilitated through a positive-feedback mechanism by the presence of aggregates that have already been formed; this type of secondary nucleation was initially identified in the context of sickle hemoglobin aggregation (8) , but has been now found to also play an essential role in the mechanism of amyloid formation for both major variants of the Aβ peptide (9, 10) as well for α-synuclein (11) and a peptide derived from the amyloidogenic protein islet amyloid polypeptide precursor (12) . In light of this significant complexity at the molecular level, what is a fruitful way to make progresses in understanding the mechanisms of protein aggregation and develop strategies to prevent its occurrence?
The International Union of Pure and Applied Chemistry definition of an "acceptable mechanism" for a chemical reaction states that it "must be consistent [...] with the [experimentally observed] rate law [...]" (13) . Indeed chemical kinetics have been widely used in many areas of chemistry as a tool for obtaining mechanistic conclusions for small molecule reactions by connecting macroscopic observations and microscopic steps in a reaction. Therefore, a core strategy in the context of protein self-assembly consists of exploiting the knowledge of the kinetics of aggregation reactions, which can be experimentally obtained through macroscopic measurements, such as the acquisition of the time evolution of the aggregated material. However, the applicability of chemical kinetics to protein aggregation has been hampered for many years by the fact that "the rate law" for the complex reaction network underlying protein aggregation has been challenging to define based on molecular level events. Recent years, however, have seen a transformation both in the area of kinetic theory as well as in experimental methodology, and it is now becoming possible to use the full power of chemical kinetics to answer mechanistic questions for an increasing number of protein aggregation-related systems (9, 12, 14) . (7) show that the zinc ion has a protective role against the formation of fibrils from the Aβ peptide, which is closely associated with Alzheimer's disease, and that this activity of the metal ion originates from the specific inhibition of the elongation rate of fibrils by monomers (B, Center). One of the central prerequisites in the context of drug discovery against neurodegenerative diseases is the understanding of how inhibitors or promoters of aggregation of peptides and proteins can perturb the reaction on a microscopic level (15) . In PNAS, Abelein et al. (7) apply the kinetic strategy to address this question for the aggregation of the Aβ peptide in the presence of a physiologically relevant component, the zinc ion. The general chemical kinetic approach, which is followed here by Abelein et al., can be divided into two main steps (15) .
The first part of the analysis consists of identifying the mechanism of aggregation of the peptide or protein in the absence of the investigated molecular modulator. In this context, one of the major recent advances in chemical kinetics applied to protein aggregation is represented by the analysis of the halftimes of the reaction profiles as a function of the initial peptide or protein concentration. Indeed, this scaling law contains robust information about the microscopic mechanism underlying the aggregation process (9, 16) .
After the aggregation mechanism in the absence of modulator has been identified, the second part of the kinetic approach consists of repeating the analysis in the presence of the molecular modulator, and comparing the behaviors observed in the absence and in the presence of the compound. This approach has recently shown that certain compounds can alter the global aggregation rate by perturbing specifically a single microscopic event, without modifying the overall aggregation mechanism (16) . This behavior leads to a characteristic change in the shapes of the macroscopic kinetic profiles, as shown in Fig. 1 . In PNAS, Abelein et al. (7) prove that the microscopic mechanism is not perturbed by zinc, and is still dominated by the same processes observed in the absence of the metal ion. The presence of zinc does, however, delay the aggregation process by inhibiting significantly and exclusively only the elongation of fibrils by monomer.
This result demonstrates the power of chemical kinetics in the analysis of microscopic mechanisms underlying complex multistep reaction systems. However, although this method allows one to establish which species are reacting at what rate, chemical kinetics alone is not sufficient to elucidate fully the structural details of these interactions. To address this aspect of the problem, kinetic analysis must be coupled with experimental methods that are able to monitor binding reactions. Examples of these techniques include calorimetric and imaging techniques, surface plasmon resonance, and quartz crystal microbalance biosensors. In PNAS, Abelein et al. (7) apply NMR spectroscopy, a particularly powerful method to characterize protein structures in solution, to elucidate at the molecular level the binding between the zinc ion and the Aβ peptide. This approach yields a detailed description of which region of the peptide interacts with the ion, as well as the affinity and the dynamics of this interaction. Thus, the characterization of binding reactions, together with the mechanistic picture obtained by chemical kinetic analysis, provides a comprehensive description of the inhibition mechanism of compounds against the formation of amyloid fibrils (15, 16) .
A fundamental prerequisite for the application of this platform is the acquisition of quantitative and reproducible experimental data. The complexity of the aggregation reaction network, which includes the presence of feedback mechanisms, makes the cascade of microscopic events very prone to modulation by physico-chemical factors, such as ionic strength, pH, mechanical forces, and solvent composition, which often lead to fundamental differences in the aggregation mechanism and in the aggregate morphology. Indeed, polymorphism of amyloid structures is often observed even within samples of homogeneous composition (17, 18) . Therefore, it is essential that all environmental factors are carefully controlled during the design and performance of experiments to enable robust analysis of the aggregation data.
Abelein et al. (7) define the zinc ion as a "minimal" chaperone for its capacity to inhibit the aggregation process, in analogy with the role of molecular chaperones, crucial components of the protein homeostasis network that have recently been suggested to be able to interfere with aberrant protein aggregation (19, 20) . This protective role of the zinc ion against Aβ aggregation found by Abelein et al. (7) contrasts with the neurotoxic effect reported for other metal ions, in particular aluminum, which is suggested as a risk factor in the development of Alzheimer's disease (21) . It is expected that in the near future additional mechanistic studies investigating a large number of components can provide a detailed global picture of the mechanisms by which different naturally occurring compounds modulate the formation of amyloid fibrils in living systems.
Clearly many aspects of this complex problem still remain open, in particular regarding the situation occurring in the complex environment of the cells, where a large variety of additional factors, including crowding and the presence of a very heterogeneous mixture of components, may alter the picture of the process emerging in reductionist model systems. The work of Abelein et al. (7) is a remarkable demonstration of how advances in the understanding of a complex aggregation reaction mechanism can be achieved by a combination of chemical kinetic analysis and experimental characterization, and how the molecular effects that alter interactions between individual peptides and proteins can be translated into observable differences in the macroscopic behavior. Even though the species involved in this study, zinc ions, are unlikely to form the basis for a therapeutic strategy as such, the power of the approach demonstrated by Abelein et al. (7) for controlling protein aggregation raises the hope that, in the future, this strategy will pave the way to a rational design of potent inhibitors of aggregation.
